BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/1/2016 11:49:00 AM | Browse: 1131 | Download: 2530
 |
Received |
|
2016-03-15 09:34 |
|
Peer-Review Started |
|
2016-03-17 17:00 |
|
To Make the First Decision |
|
2016-03-18 16:34 |
|
Return for Revision |
|
2016-03-18 18:56 |
|
Revised |
|
2016-03-18 21:02 |
|
Second Decision |
|
2016-04-26 16:46 |
|
Accepted by Journal Editor-in-Chief |
|
2016-04-26 21:12 |
|
Accepted by Executive Editor-in-Chief |
|
2016-05-11 16:42 |
|
Articles in Press |
|
2016-05-11 16:42 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-07-20 09:02 |
|
Publish the Manuscript Online |
|
2016-08-01 11:49 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Retrospective Study |
| Article Title |
Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Philipp Horvath, Stefan Beckert, Florian Struller, Alfred Königsrainer and Ingmar Königsrainer |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ingmar Königsrainer, MD, Department of General, Visceral and Transplant Surgery, University of Tübingen, Comprehensive Cancer Center, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany. koenigsrainer@med.uni-tuebingen.de |
| Key Words |
Pseudomyxoma peritonei; Mitomycin C; Oxaliplatin; Hyperthermic intraperitoneal chemotherapy; Postoperative leukopenia |
| Core Tip |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the therapy of choice for patients with pseudomyxoma peritonei. Nevertheless this treatment is a major undertaking associated with elevated morbidity. The occurrence of postoperative leukopenia can deteriorate the patient’s outcome by triggering complications like anastomotic insufficiencies or intraabdominal abscess formations so that surgeons must be aware that special patient subsets (primarily older patients and females) exist that are at a higher risk for developing post-HIPEC leukopenia. |
| Publish Date |
2016-08-01 11:49 |
| Citation |
Horvath P, Beckert S, Struller F, Königsrainer A, Königsrainer I. Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei. World J Gastrointest Pharmacol Ther 2016; 7(3): 434-439 |
| URL |
http://www.wjgnet.com/2150-5349/full/v7/i3/434.htm |
| DOI |
http://dx.doi.org/10.4292/wjgpt.v7.i3.434 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
